Adage Capital Partners Portfolio holdings
AUM
$59.3B
1-Year Return
26.26%
This Quarter Return
+10.77%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$55.5B
AUM Growth
+$4.77B
(+9.4%)
Cap. Flow
+$398M
Cap. Flow
% of AUM
0.72%
Top 10 Holdings %
Top 10 Hldgs %
23.64%
Holding
1,156
New
140
Increased
288
Reduced
383
Closed
138
Top Buys
| 1 |
GE Aerospace
GE
|
+$266M |
| 2 |
Dollar Tree
DLTR
|
+$251M |
| 3 |
Burlington
BURL
|
+$211M |
| 4 |
Tesla
TSLA
|
+$153M |
| 5 |
Carrier Global
CARR
|
+$139M |
Top Sells
| 1 |
XEC
CIMAREX ENERGY CO
XEC
|
+$625M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$189M |
| 3 |
Northrop Grumman
NOC
|
+$166M |
| 4 |
Johnson & Johnson
JNJ
|
+$131M |
| 5 |
General Dynamics
GD
|
+$126M |
Sector Composition
| 1 | Technology | 23.75% |
| 2 | Healthcare | 15.7% |
| 3 | Financials | 13.31% |
| 4 | Consumer Discretionary | 11.56% |
| 5 | Industrials | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
Las Vegas Sands
LVS
$36.9B
| $13.8M | 0.02% |
366,300
-2,700
| -0.7% | -$102K |
|
602
Fortune Brands Innovations
FBIN
$7.29B
| $13.8M | 0.02% |
150,598
-4,563
| -3% | -$417K |
|
|
FACA
603
DELISTED
Figure Acquisition Corp. I
FACA
| $13.7M | 0.02% |
1,400,000
+17,072
| +1% | +$167K |
|
|
GEEXU
604
DELISTED
Games & Esports Experience Acquisition Corp. Unit
GEEXU
| $13.7M | 0.02% |
+1,350,000
| New | +$13.7M |
|
|
AEAC
605
DELISTED
Authentic Equity Acquisition Corp. Class A ordinary share
AEAC
| $13.7M | 0.02% |
1,400,000
| – | – |
|
606
Praxis Precision Medicines
PRAX
$858M
| $13.6M | 0.02% |
46,139
+5,334
| +13% | +$1.58M |
|
607
RenaissanceRe
RNR
$11.3B
| $13.5M | 0.02% |
80,000
| – | – |
|
|
VERV
608
DELISTED
Verve Therapeutics
VERV
| $13.5M | 0.02% |
367,237
-102,763
| -22% | -$3.79M |
|
609
Zurn Elkay Water Solutions
ZWS
$7.82B
| $13.5M | 0.02% |
+370,000
| New | +$13.5M |
|
610
AAR Corp
AIR
$2.69B
| $13.4M | 0.02% |
343,750
+17,780
| +5% | +$694K |
|
611
Marqeta
MQ
$2.73B
| $13.4M | 0.02% |
778,022
+393,022
| +102% | +$6.75M |
|
612
Insulet
PODD
$24.6B
| $13.3M | 0.02% |
+50,000
| New | +$13.3M |
|
613
Host Hotels & Resorts
HST
$12B
| $13.2M | 0.02% |
760,833
+9,800
| +1% | +$170K |
|
614
Robert Half
RHI
$3.66B
| $13.2M | 0.02% |
118,600
+48,100
| +68% | +$5.36M |
|
|
SLN
615
Silence Therapeutics
SLN
$254M
| $13.1M | 0.02% |
550,000
+105,556
| +24% | +$2.52M |
|
616
OPAL Fuels
OPAL
$61.5M
| $13.1M | 0.02% |
1,313,400
-936,600
| -42% | -$9.35M |
|
617
Aclaris Therapeutics
ACRS
$225M
| $13.1M | 0.02% |
899,997
-175,369
| -16% | -$2.55M |
|
|
ITCI
618
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $13.1M | 0.02% |
250,000
-50,000
| -17% | -$2.62M |
|
|
NKGN
619
DELISTED
NKGen Biotech, Inc. Common Stock
NKGN
| $13.1M | 0.02% |
1,350,000
| – | – |
|
|
AGCB
620
DELISTED
Altimeter Growth Corp. 2
AGCB
| $13.1M | 0.02% |
1,325,000
| – | – |
|
621
LanzaTech
LNZA
$44.4M
| $13M | 0.02% |
13,500
+9,000
| +200% | +$8.69M |
|
622
Hologic
HOLX
$14.8B
| $13M | 0.02% |
170,086
-105,900
| -38% | -$8.11M |
|
623
Kymera Therapeutics
KYMR
$3.09B
| $13M | 0.02% |
205,000
-45,000
| -18% | -$2.86M |
|
624
Lantheus
LNTH
$3.65B
| $13M | 0.02% |
450,000
-50,000
| -10% | -$1.44M |
|
625
Dentsply Sirona
XRAY
$2.83B
| $13M | 0.02% |
232,900
-1,300
| -0.6% | -$72.5K |
|